The new EU regulation introduces Joint Clinical Assessments that will run in parallel with EMA approvals, delivering comparative effectiveness data within one month of market authorisation.

A new suit has been filed against IBM claiming that the plan’s target date fund (TDF) series “has suffered over $1.9 billion in losses resulting from the fiduciary breaches at issue and remain ...

Semaglutide, tirzepatide, and dulaglutide have similar gastrointestinal safety profiles among patients with type 2 diabetes, ...

Barratt Redrow has reported an increase in completions and a rise in the value of its forward order book. In a trading update ...

For more than three decades, modern CPUs have relied on speculative execution to keep pipelines full. When it emerged in the ...

In people with cancer, CBT-I may slightly improve insomnia severity, sleep quality, and most sleep diary parameters without introducing additional unwanted or harmful events. However, we are very ...

Q3 2025 Earnings Call November 6, 2025 8:30 AM ESTCompany ParticipantsJason English - Interim Head of Investor ...

Belimumab is linked to a reduced risk for all-cause mortality compared with azathioprine, methotrexate, and mycophenolate among patients with nonrenal SLE.

Jaala Hinchcliffe’s under siege at DPS, inside the building where politics and public service collide in the most combustible ...

Three popular GLP-1 receptor agonists carried similar risks for serious gastrointestinal (GI) events among adults with type 2 ...

Mind Medicine Australia clinic joins Psyence BioMed’s expanding network of clinical sites as enrollment accelerates in the landmark Phase IIb study for Adjustment Disorder in palliative careNEW YORK, ...

In clinics across Europe, older adults tried a new way to sharpen fading sight. It involved a wafer-thin chip and smart ...